Literature DB >> 17880498

Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.

Hsing-Wen Wang1, Elizabeth Rickter, Min Yuan, E Paul Wileyto, Eli Glatstein, Arjun Yodh, Theresa M Busch.   

Abstract

Photodynamic therapy (PDT) regimens that conserve tumor oxygenation are typically more efficacious, but require longer treatment times. This makes them clinically unfavorable. In this report, the inverse pairing of fluence rate and photosensitizer dose is investigated as a means of controlling oxygen depletion and benefiting therapeutic response to PDT under conditions of constant treatment time. Studies were performed for Photofrin-PDT of radiation-induced fibrosarcoma tumors over fluence rate and drug dose ranges of 25-225 mW cm(-2) and 2.5-10 mg kg(-1), respectively, for 30 min of treatment. Tumor response was similar among all inverse regimens tested, and, in general, tumor hemoglobin oxygen saturation (SO2) was well conserved during PDT, although the highest fluence rate regimen (225 mWx2.5 mg) did lead to a modest but significant reduction in SO2. Regardless, significant direct tumor cell kill (>1 log) was detected during 225 mWx2.5 mg PDT, and minimal normal tissue toxicity was found. PDT effect on tumor oxygenation was highly associated with tumor response at 225 mWx2.5 mg, as well as in all other regimens tested. These data suggest that high fluence rate PDT can be carried out under oxygen-conserving, efficacious conditions at low photosensitizer dose. Clinical confirmation and application of these results will be possible through use of minimally invasive oxygen and photosensitizer monitoring technologies, which are currently under development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880498     DOI: 10.1111/j.1751-1097.2007.00139.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  13 in total

1.  Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate.

Authors:  Theresa M Busch; Hsing-Wen Wang; E Paul Wileyto; Guoqiang Yu; Ralph M Bunte
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

2.  A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.

Authors:  Haixia Qiu; Michele M Kim; Rozhin Penjweini; Jarod C Finlay; Theresa M Busch; Tianhao Wang; Wensheng Guo; Keith A Cengel; Charles B Simone; Eli Glatstein; Timothy C Zhu
Journal:  Photochem Photobiol       Date:  2017-02-22       Impact factor: 3.421

Review 3.  Intraoperative adjuncts for malignant pleural mesothelioma.

Authors:  Warren Ho Chan; David J Sugarbaker; Bryan M Burt
Journal:  Transl Lung Cancer Res       Date:  2017-06

4.  Radical pleurectomy and photodynamic therapy for malignant pleural mesothelioma.

Authors:  Joseph S Friedberg
Journal:  Ann Cardiothorac Surg       Date:  2012-11

5.  Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.

Authors:  Theresa M Busch; Xiaoman Xing; Guoqiang Yu; Arjun Yodh; E Paul Wileyto; Hsing-Wen Wang; Turgut Durduran; Timothy C Zhu; Ken Kang-Hsin Wang
Journal:  Photochem Photobiol Sci       Date:  2009-10-15       Impact factor: 3.982

Review 6.  Targeted photodynamic therapy in head and neck squamous cell carcinoma: heading into the future.

Authors:  Sophie Marchal; Gilles Dolivet; Henri-Pierre Lassalle; François Guillemin; Lina Bezdetnaya
Journal:  Lasers Med Sci       Date:  2015-01-07       Impact factor: 3.161

Review 7.  The role of intracavitary therapies in the treatment of malignant pleural mesothelioma.

Authors:  Pietro Bertoglio; Vittorio Aprile; Marcello Carlo Ambrogi; Alfredo Mussi; Marco Lucchi
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

8.  Macroscopic singlet oxygen modeling for dosimetry of Photofrin-mediated photodynamic therapy: an in-vivo study.

Authors:  Haixia Qiu; Michele M Kim; Rozhin Penjweini; Timothy C Zhu
Journal:  J Biomed Opt       Date:  2016-08-01       Impact factor: 3.170

9.  Hemodynamic and metabolic diffuse optical monitoring in a mouse model of hindlimb ischemia.

Authors:  Rickson C Mesquita; Nicolas Skuli; Meeri N Kim; Jiaming Liang; Steve Schenkel; Amar J Majmundar; M Celeste Simon; Arjun G Yodh
Journal:  Biomed Opt Express       Date:  2010-10-15       Impact factor: 3.732

10.  1O2 determined from the measured PDT dose and 3O2 predicts long-term response to Photofrin-mediated PDT.

Authors:  Rozhin Penjweini; Michele M Kim; Yi Hong Ong; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2020-01-24       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.